Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: ghmm who wrote (376)	1/2/2012 5:13:29 PM
From: fred hayes	Respond to of 400

Don't think so, even in the biotech mania days, but not sure. Don't recall numbers in this ballpark. Remember initial Genentech offering went up 3x or so on the offering day, but not enuf shares to get anywhere near the vrus mc...

To: ghmm who wrote (376)	1/2/2012 5:49:07 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 400

If when you say --'before having a product approved'--if you mean not approved by the FDA, then my answer will be General Electric. Again this is assuming you mean a biotech product under the stated definition of biotechnology. I bet I have some scratching their heads over why General Electric would be my answer!